Announcements Trials
Browse Landscape

Phase

Phase 2 18Phase 3 12Phase 1/2 5Phase 1 5Phase 2/3 4Phase NA 2Phase EARLY_PHASE1 1

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Glioblastoma 2Central Nervous System Neoplasms 2Medulloblastoma 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma 1Glioma 1

Interventions

Magnetic Resonance Spectroscopy 17Blood Specimen Collection 8Bevacizumab 8Temozolomide 7Radiotherapy 5Palliative Care 4Surgical Procedures, Operative 3Restraint, Physical 3Radiation 3Biopsy 3Yoga 2Standard of Care 2Specimen Handling 2Radiotherapy, Intensity-Modulated 2Radiosurgery 2Psychosocial Intervention 2Perfusion Magnetic Resonance Imaging 2Mind-Body Therapies 2Magnetic Resonance Imaging 2Lomustine 2Gadolinium DTPA 2Elasticity Imaging Techniques 2Early Intervention, Educational 2Drug Therapy 2Diet Therapy 2Dexamethasone 2Chemotherapy, Adjuvant 2Aminolevulinic Acid 22-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2tislelizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Glioblastoma × Lomustine × Clear all
NCT05410301 2023-04-21

Golden Halo, Static Magnetic and Electric Field Device, in Recurrent Glioblastoma

University of Iowa

Phase NA Withdrawn
CNS

Glioblastoma

NCT02076152 2021-07-30

FMISO PET Study of Glioblastoma

Massachusetts General Hospital

Phase NA Completed
11 enrolled 11 charts
CNS

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡